Statistics for AxoGen (id:5348 AXGN)
Valuation metrics
Market cap
653.52M
Enterprise value
700.30M
Trailing P/E (ttm)
-30.67
Forward P/E
47.90
PEG ratio
47.90
Price/Sales (ttm)
3.61
Price/Book (mrq)
6.57
Enterprise Value/Revenue
3.87
Enterprise Value/EBITDA
-378.95
Overview
Shares outstanding
44.01M
Float
38.54M
Shares short
1.09M
% Held by insiders
5.00%
% Held by institutions
3.00%
Average volume (10 days)
184.55K
Average volume (90 days)
Price summary
52-Week low
5.55
52-Week high
15.90
52-Week change
54.35%
Beta
1.13
50-Day moving average
13.88
200-Day moving average
10.28
Dividends and splits
Forward annual dividend rate
4.00
Forward annual dividend yield
3.00
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
February 12, 2010
Ex-dividend date
January 27, 2010
Last split factor
2:1
Last split date
July 11, 1994
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
-7.91%
Operating margin
3.00%
Operational effectiveness
Return on assets
-2.75%
Return on equity
-14.51%
Income statement
Revenue (ttm)
4.16
Revenue per share (ttm)
4.16
Quarterly revenue growth (yoy)
3.00
Gross profit (ttm)
127.87M
EBITDA
-1,848,000.00
Net income to common (ttm)
-14,307,000.00
Diluted EPS (ttm)
3.00
Quarterly earnings growth (yoy)
17.86%
Balance sheet
Total cash (mrq)
24.53M
Total cash per share (mrq)
3.00
Total debt (mrq)
71.31M
Total Debt/Equity (mrq)
71.73
Current ratio (mrq)
374.50%
Book value per share (mrq)
2.26
Cash flow
Cash flow statement
-4,411,000.00
Levered free cash flow (LFCF)
-4,372,250.00